TurtleTree Labs, a Singapore-based startup that leverages biotechnology to create the full nutritional content of milk, has raised an undisclosed amount of pre-seed funding in a round led by alternative protein-focused venture capital fund Lever VC.
Asset management firm KBW Ventures and VC fund K2 Global also participated in the round, according to a statement.
Using proprietary mammary cell-based methods, TurtleTree claims to be the first biotech company in the world with the ability to create milk from all mammals.
“The seed funding will be used to further build out the company’s scientific team and to create additional prototypes,” said TurtleTree chief strategist and co-founder Max Rye. Fengru Lin, the CEO of TurtleTree, added that the company is now focused on making hires during its early stages to provide the support it needs for rapid acceleration.
naijalatest.news.blog 